Targeting high-risk young patients for statin therapy

JAMA

Volumn 292, Issue 3, 2004, Pages 377-378

  Gotto, Antonio M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; STATINE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADOLESCENT; CARDIOVASCULAR RISK; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; CARDIOVASCULAR DISEASE; CHILD; HYPERLIPOPROTEINEMIA TYPE 2; NOTE;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II;

EID: 3142689780     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.3.377     Document Type: Editorial

References (14)

1. Ose L. Familial hypercholesterolemia from children to adults. Cardiovasc Drugs Ther. 2002;16:289-293.
2. Civiera F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55-68.
3. Stamler J, Fortmann SP, Levy RI, Prineas RJ, Tell G. Primordial prevention of cardiovascular disease risk factors: panel summary. Prev Med. 1999;29:S130-S135.
4. Gordon BR, Stein E, Jones P, Illingworth DR. Indications for low-density lipoprotein apheresis. Am J Cardiol. 1994;74:1109-1112.
5. Gagne C, Gaudet D, Bruckert E; Ezetimibe Study Group. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation. 2002;105:2469-2475.
6. Dirisamer A, Hachemian N, Bucek RA, Wolf F, Reiter M, Widhalm K. The effect of low-dose simvastatin children with familial hypercholesterolemia: a 1-year observation. Eur J Pediatr. 2003;162:421-425.
7. Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292:331-337.
8. National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89:525-584.
9. Tonstad S. Treatment of children with familial hypercholesterolemia. Expert Rev Cardiovasc Ther. 2003;1:135-141.
10. de Jongh S, Kerckhoffs MC, Grootenhuis MA, Bakker HD, Heymans HS, Last BF. Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents. Acta Paediatr. 2003;92:1096-1101.
11. Pfeffer NL, Veach PM, LeRoy BS. An investigation of genetic counselors' discussion of genetic discrimination with cancer risk patients. J Genet Couns. 2003;12:419-438.
12. Swanson JR, Pearson TA. Screening family members at high risk for coronary disease: why isn't it done? Am J Prev Med. 2001;20:50-55.
13. OTC statins: a bad decision for public health. Lancet. 2004;363:1659.
14. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.